Prescription drug advertising can be downright comical. Between middle-aged men petting dogs on the banks of rivers in cholesterol drug ads, and narrators rattling off a litany of potential side ...

The Federal Trade Commission is expected to release a comprehensive study on the competitive impact of authorized generic drugs in early 2010, while a new report concludes these versions of drugs ...

The original version of this story was published on Legal Times The Federal Trade Commission recently announced its intention to issue broad subpoenas to almost 200 companies in the pharmaceutical ...

WASHINGTON — Branded drugs sold under their generic names at a reduced price can reduce retail and wholesale drug prices, according to a new report by the Federal Trade Commission. The FTC report ...

Do the Compromises of Hatch-Waxman Need a Further Look? In Teva Pharmaceuticals Industries, Ltd. v. Crawford, decided this June, the U.S. Court of Appeals for the District of Columbia, in affirming a ...

Please provide your email address to receive an email when new articles are posted on . In a cross-sectional study, Dusetzina and colleagues analyzed data from Medicare Prescription Drug Plan ...

The use of generic drugs continues to rise. Only seven years ago, 38 percent of U.S. drugs were generics. The forecast for 2007 is 48 percent. For the most part, this is good news for the generic drug ...

One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.

Amneal is debuting an authorized generic of Jazz Pharmaceuticals' Xyrem (Sodium Oxybate) oral solution CIII. Sodium Oxybate oral solution, 0.5 g/ml is a central nervous system depressant indicated for ...

(RTTNews) - Specialty pharmaceutical company Collegium Pharmaceutical, Inc. (COLL) announced Monday it has entered into an authorized generic agreement with Hikma Pharmaceuticals USA Inc., pursuant to ...

Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors are concerned patients may have delays switching to alternatives ...